HEALTHSTAT NEWS
Opinion: The smart way to regulate the peptide boom
Americans are increasingly using peptide compounds for health and performance from unregulated sources, creating risks. The FDA, led by Kyle Diamantas, has an opportunity to regulate peptides without resorting to a crackdown or uncontrolled access.
Mentioned
Related Signal
Adjacent reporting
- Thinking about peptides? Doctors reveal key dos and don’ts as ‘Wild West’ market grows
- The FDA considers easing limits on peptides use
- ‘Wild West’ peptide craze surges beyond GLP-1s as FDA faces pressure to ease access
- RFK Jr.'s peptide push could become next wellness boom
- Inside the booming, gray-market world of injectable peptides